Mechanistic analyses reveal that Pueraria montana var. lobata (Willd.) is effective in inhibiting ovarian cancer progression.
The study explored the anti-tumor effects of P. montana var. lobata (Willd.) in ovarian cancer. Seven active ingredients were identified, along with key targets and pathways for potential treatment. Animal experiments showed promising results in inhibiting cancer progression. Further research and clinical trials are recommended.
- Lin C, Su T and Ye YJ (2024).
- Naunyn Schmiedebergs Arch Pharmacol.
- PubMed:
- 38809293